Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target

Metabolic aberrations impact the pathogenesis of multiple sclerosis (MS) and possibly can provide clues for new treatment strategies. Using untargeted metabolomics, we measured serum metabolites from 35 patients with relapsing-remitting multiple sclerosis (RRMS) and 14 healthy age-matched controls....

Descripción completa

Detalles Bibliográficos
Autores principales: Zahoor, Insha, Suhail, Hamid, Datta, Indrani, Ahmed, Mohammad Ejaz, Poisson, Laila M., Waters, Jeffrey, Rashid, Faraz, Bin, Rui, Singh, Jaspreet, Cerghet, Mirela, Kumar, Ashok, Hoda, Md Nasrul, Rattan, Ramandeep, Mangalam, Ashutosh K., Giri, Shailendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231486/
https://www.ncbi.nlm.nih.gov/pubmed/35700359
http://dx.doi.org/10.1073/pnas.2123265119

Ejemplares similares

Ejemplares similares